BMO senior economist Sal Guatieri points out the severe negative effects of the trade war on industrial investment, ...

The FDA said Dexcom issued a correction for certain continuous glucose monitor apps due to a software design error that ...

Shares of medical device company DexCom (NASDAQ:DXCM) fell 7.4% in the morning session after a short-seller report from Hunterbrook Capital alleged issues with the company's G7 glucose monitoring ...

U.S. equities climbed to new records on Thursday, led by small caps and technology, as investors embraced the Federal Reserve’s latest rate cut and upbeat economic data The S&P 500 gained 0.48% to ...

The Dow Jones Industrial Average joined other indexes higher after surprise weekly jobless claims. Nvidia stock jumps on its ...

AUSTIN, Texas and TOKYO, Sept. 18, 2025 /PRNewswire/ — According to DataM Intelligence, the global AI in remote patient ...

Most Wall Street “suits” are allergic to dividend cuts. These spreadsheet jockeys sooooo lack imagination. They prefer linear ...

According to DataM Intelligence, the global AI in remote patient monitoring market reached US$ 5.45 billion in 2023, with a rise to US$ ...

The FDA identified a recall of smartphone apps for Dexcom (Nasdaq:DXCM) continuous glucose monitors as the most serious type.

Medical technology companies are facing the type of patent litigation once reserved for tech giants, and they’re responding ...

Mark Strassmann is CBS News' senior national correspondent based in Atlanta. He covers a wide range of stories, including space exploration. Strassmann is also the senior national correspondent for ...

Dexcom, Inc, has issued a recall for G7 Apps and ONE+ Apps because of a software design error failing to alert users of ...